These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Effects of new 5-amino-1,3,4-thiadiazole-2-sulfonamide derivatives on human carbonic anhydrase isozymes. Kasimoğullari R, Bülbül M, Günhan H, Güleryüz H. Bioorg Med Chem; 2009 May 01; 17(9):3295-301. PubMed ID: 19362844 [Abstract] [Full Text] [Related]
43. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition. Weber A, Casini A, Heine A, Kuhn D, Supuran CT, Scozzafava A, Klebe G. J Med Chem; 2004 Jan 29; 47(3):550-7. PubMed ID: 14736236 [Abstract] [Full Text] [Related]
44. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide. Cecchi A, Winum JY, Innocenti A, Vullo D, Montero JL, Scozzafava A, Supuran CT. Bioorg Med Chem Lett; 2004 Dec 06; 14(23):5775-80. PubMed ID: 15501039 [Abstract] [Full Text] [Related]
45. Investigating the specific interactions between carbonic anhydrase and a sulfonamide inhibitor by single-molecule force spectroscopy. Kamper SG, Porter-Peden L, Blankespoor R, Sinniah K, Zhou D, Abell C, Rayment T. Langmuir; 2007 Dec 04; 23(25):12561-5. PubMed ID: 17973506 [Abstract] [Full Text] [Related]
46. Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides. Innocenti A, Firnges MA, Antel J, Wurl M, Scozzafava A, Supuran CT. Bioorg Med Chem Lett; 2005 Feb 15; 15(4):1149-54. PubMed ID: 15686931 [Abstract] [Full Text] [Related]
47. Topological modeling of lipophilicity, diuretic activity, and carbonic inhibition activity of benzene sulfonamides: a molecular connectivity approach. Jaiswal M, Khadikar PV, Supuran CT. Bioorg Med Chem Lett; 2004 Nov 15; 14(22):5661-6. PubMed ID: 15482943 [Abstract] [Full Text] [Related]
48. S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases. Lopez M, Paul B, Hofmann A, Morizzi J, Wu QK, Charman SA, Innocenti A, Vullo D, Supuran CT, Poulsen SA. J Med Chem; 2009 Oct 22; 52(20):6421-32. PubMed ID: 19827837 [Abstract] [Full Text] [Related]
49. Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma. Mincione F, Starnotti M, Masini E, Bacciottini L, Scrivanti C, Casini A, Vullo D, Scozzafava A, Supuran CT. Bioorg Med Chem Lett; 2005 Sep 01; 15(17):3821-7. PubMed ID: 16039853 [Abstract] [Full Text] [Related]
50. Carbonic anhydrase inhibitors: the X-ray crystal structure of the adduct of N-hydroxysulfamide with isozyme II explains why this new zinc binding function is effective in the design of potent inhibitors. Temperini C, Winum JY, Montero JL, Scozzafava A, Supuran CT. Bioorg Med Chem Lett; 2007 May 15; 17(10):2795-801. PubMed ID: 17346964 [Abstract] [Full Text] [Related]
51. Carbonic anhydrase-encoded dynamic constitutional libraries: toward the discovery of isozyme-specific inhibitors. Nasr G, Petit E, Vullo D, Winum JY, Supuran CT, Barboiu M. J Med Chem; 2009 Aug 13; 52(15):4853-9. PubMed ID: 19580287 [Abstract] [Full Text] [Related]
52. Carbonic anhydrase inhibitors: aromatic and heterocyclic sulfonamides incorporating adamantyl moieties with strong anticonvulsant activity. Ilies MA, Masereel B, Rolin S, Scozzafava A, Câmpeanu G, Cîmpeanu V, Supuran CT. Bioorg Med Chem; 2004 May 15; 12(10):2717-26. PubMed ID: 15110853 [Abstract] [Full Text] [Related]
53. Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies. Güzel O, Temperini C, Innocenti A, Scozzafava A, Salman A, Supuran CT. Bioorg Med Chem Lett; 2008 Jan 01; 18(1):152-8. PubMed ID: 18024029 [Abstract] [Full Text] [Related]
54. Carbonic anhydrase inhibitors: Selective inhibition of the extracellular, tumor-associated isoforms IX and XII over isozymes I and II with glycosyl-thioureido-sulfonamides. Smaine FZ, Winum JY, Montero JL, Regainia Z, Vullo D, Scozzafava A, Supuran CT. Bioorg Med Chem Lett; 2007 Sep 15; 17(18):5096-100. PubMed ID: 17646100 [Abstract] [Full Text] [Related]
55. Conformational Changes in Alkyl Chains Determine the Thermodynamic and Kinetic Binding Profiles of Carbonic Anhydrase Inhibitors. Glöckner S, Ngo K, Sager CP, Hüfner-Wulsdorf T, Heine A, Klebe G. ACS Chem Biol; 2020 Mar 20; 15(3):675-685. PubMed ID: 32027480 [Abstract] [Full Text] [Related]
56. Comparative analysis of 10 small molecules binding to carbonic anhydrase II by different investigators using Biacore technology. Papalia GA, Leavitt S, Bynum MA, Katsamba PS, Wilton R, Qiu H, Steukers M, Wang S, Bindu L, Phogat S, Giannetti AM, Ryan TE, Pudlak VA, Matusiewicz K, Michelson KM, Nowakowski A, Pham-Baginski A, Brooks J, Tieman BC, Bruce BD, Vaughn M, Baksh M, Cho YH, Wit MD, Smets A, Vandersmissen J, Michiels L, Myszka DG. Anal Biochem; 2006 Dec 01; 359(1):94-105. PubMed ID: 17007806 [Abstract] [Full Text] [Related]
57. Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides. Wilkinson BL, Bornaghi LF, Houston TA, Innocenti A, Vullo D, Supuran CT, Poulsen SA. J Med Chem; 2007 Apr 05; 50(7):1651-7. PubMed ID: 17343373 [Abstract] [Full Text] [Related]
58. Two-prong inhibitors for human carbonic anhydrase II. Roy BC, Banerjee AL, Swanson M, Jia XG, Haldar MK, Mallik S, Srivastava DK. J Am Chem Soc; 2004 Oct 20; 126(41):13206-7. PubMed ID: 15479058 [Abstract] [Full Text] [Related]
59. Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference. Temperini C, Cecchi A, Scozzafava A, Supuran CT. Bioorg Med Chem; 2009 Feb 01; 17(3):1214-21. PubMed ID: 19119014 [Abstract] [Full Text] [Related]
60. Studying how different terminal groups change the motion of H2NSO2C6H4CONH(EG)3R when bound to the active site of human carbonic anhydrase II. Chin DN, Lau AY, Whitesides GM. J Org Chem; 1998 Feb 20; 63(4):938-45. PubMed ID: 14994755 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]